Gsk Stockmann

Gsk Stockmann company information, Employees & Contact Information

Explore related pages

Related company profiles:

GSK Stockmann. About us. GSK Stockmann is a leading independent European corporate law firm with over 250 professionals across our offices in Germany, Luxembourg and London. GSK Stockmann is the law firm of choice for Real Estate and Financial Services. In addition, we have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. With wide-ranging expertise including M&A, private equity & venture capital, dispute resolution, tax, compliance, restructuring, IP & IT, data protection, antitrust and employment law, our dedicated teams have the experience to find the right solution for your business needs. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: Your perspective. For further information, please visit: www.gsk.de www.gsk-lux.com Legal notice GSK Stockmann: http://www.gsk.de/en/legal-notice/

Company Details

Employees
488
Founded
-
Address
Karl-Scharnagl-Ring 8, München,80539,germany
Industry
Legal Services
NAICS
Legal Services
Offices of Notaries
Other Legal Services
Title Abstract and Settlement Offices
All Other Legal Services
Website
gsk.de
HQ
München
Looking for a particular Gsk Stockmann employee's phone or email?

Gsk Stockmann Questions

News

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech - PharmaLive

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech PharmaLive

Mishcon de Reya advises Relation on strategic collaborations with GSK - Mishcon de Reya LLP

Mishcon de Reya advises Relation on strategic collaborations with GSK Mishcon de Reya LLP

Pfizer to Sell Stake in Haleon Following GSK De-Merger - BioSpace

Pfizer to Sell Stake in Haleon Following GSK De-Merger BioSpace

History and heritage - GSK

History and heritage GSK

CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus - CEPI

CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus CEPI

Is GSK an Attractive Drug Stock to Add to Your Portfolio Now? - Yahoo Finance

Is GSK an Attractive Drug Stock to Add to Your Portfolio Now? Yahoo Finance

GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D - GSK

GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D GSK

US FDA Advisory Committee votes to support effectiveness and safety of GSK’s respiratory syncytial virus older adult vaccine candidate - GSK

US FDA Advisory Committee votes to support effectiveness and safety of GSK’s respiratory syncytial virus older adult vaccine candidate GSK

US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults - GSK

US FDA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults GSK

GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV) vaccine candidate for older adults - GSK

GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV) vaccine candidate for older adults GSK

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn - GSK

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn GSK

Blenrep (belantamab mafodotin) in combination receives Breakthrough Therapy Designation in China for treatment of relapsed/refractory multiple myeloma - GSK

Blenrep (belantamab mafodotin) in combination receives Breakthrough Therapy Designation in China for treatment of relapsed/refractory multiple myeloma GSK

GSK completes acquisition of Aiolos Bio - GSK

GSK completes acquisition of Aiolos Bio GSK

GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company - GSK

GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company GSK

European Commission approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk - GSK

European Commission approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk GSK

GSK sets new environmental goals of net zero impact on climate and net positive impact on nature by 2030 - GSK

GSK sets new environmental goals of net zero impact on climate and net positive impact on nature by 2030 GSK

GSK presents promising new data for bepirovirsen, an investigational treatment for chronic hepatitis B - GSK

GSK presents promising new data for bepirovirsen, an investigational treatment for chronic hepatitis B GSK

Human rights - GSK

Human rights GSK

GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment - GSK

GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment GSK

Moncef Slaoui Departs Galvani Bioelectronics Board of Directors - GSK

Moncef Slaoui Departs Galvani Bioelectronics Board of Directors GSK

Focus: How GSK plans to replenish its depleted medicine cabinet - Reuters

Focus: How GSK plans to replenish its depleted medicine cabinet Reuters

GSK to cement split with two new headquarters - Reuters

GSK to cement split with two new headquarters Reuters

GSK chief steps down in stunning move—Chutes & Ladders - Fierce Biotech

GSK chief steps down in stunning move—Chutes & Ladders Fierce Biotech

GSK's Emma Walmsley to step down as CEO in shock move, giving way to commercial lead Luke Miels - Fierce Pharma

GSK's Emma Walmsley to step down as CEO in shock move, giving way to commercial lead Luke Miels Fierce Pharma

GSK, after consumer spinoff, touts momentum for core products Cabenuva and Shingrix - Fierce Pharma

GSK, after consumer spinoff, touts momentum for core products Cabenuva and Shingrix Fierce Pharma

GSK won’t file drug patents in low-income countries - BioPharma Dive

GSK won’t file drug patents in low-income countries BioPharma Dive

GSK pays $70M to increase its access to Tempus patient data library - Mobi Health News

GSK pays $70M to increase its access to Tempus patient data library Mobi Health News

The demethylase inhibitor GSK-J4 limits inflammatory colitis by promoting de novo synthesis of retinoic acid in dendritic cells - Nature

The demethylase inhibitor GSK-J4 limits inflammatory colitis by promoting de novo synthesis of retinoic acid in dendritic cells Nature

FDA panel recommends GSK's RSV vaccine for ages 60 and up - CIDRAP

FDA panel recommends GSK's RSV vaccine for ages 60 and up CIDRAP

GSK soothes investors by settling first Zantac cancer lawsuit due for US trial - Reuters

GSK soothes investors by settling first Zantac cancer lawsuit due for US trial Reuters

Enabling Data-Driven Solubility Modeling at GSK: Enhancing Purge Predictions for Mutagenic Impurities - ACS Publications

Enabling Data-Driven Solubility Modeling at GSK: Enhancing Purge Predictions for Mutagenic Impurities ACS Publications

GSK's blood cancer drug meets main goal in late-stage trial; analysts tout comeback - Reuters

GSK's blood cancer drug meets main goal in late-stage trial; analysts tout comeback Reuters

Wake Up Narcolepsy Names De Rise, Fabrizio, Frasher to Board - Sleep Review

Wake Up Narcolepsy Names De Rise, Fabrizio, Frasher to Board Sleep Review

Advantage Pfizer: GSK stops phase 3 trials of maternal RSV vaccine after seeing safety signal - Fierce Biotech

Advantage Pfizer: GSK stops phase 3 trials of maternal RSV vaccine after seeing safety signal Fierce Biotech

Elliott fires opening salvo at GlaxoSmithKline, calling for new management to fix 'severe underperformance' - Fierce Pharma

Elliott fires opening salvo at GlaxoSmithKline, calling for new management to fix 'severe underperformance' Fierce Pharma

GSK names Luke Miels as next CEO - PMLiVE

GSK names Luke Miels as next CEO PMLiVE

GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis - Frontiers

GSK-3 Inhibitors and Tooth Repair: An Ethical Analysis Frontiers

Sanofi and GlaxoSmithKline Snag Biggest Coronavirus Vaccine Deal Yet (Published 2020) - The New York Times

Sanofi and GlaxoSmithKline Snag Biggest Coronavirus Vaccine Deal Yet (Published 2020) The New York Times

Haleon shares: can they rally post-GSK de-merger? - The Armchair Trader

Haleon shares: can they rally post-GSK de-merger? The Armchair Trader

GSK settles another California lawsuit on heartburn drug Zantac - Reuters

GSK settles another California lawsuit on heartburn drug Zantac Reuters

Unilever Pursues Glaxo and Pfizer Consumer Health Venture (Published 2022) - The New York Times

Unilever Pursues Glaxo and Pfizer Consumer Health Venture (Published 2022) The New York Times

Elliott portfolio manager behind GSK and Fresenius campaigns leaves firm - Financial Times

Elliott portfolio manager behind GSK and Fresenius campaigns leaves firm Financial Times

GSK reaches first legal settlement over heartburn medicine Zantac - Financial Times

GSK reaches first legal settlement over heartburn medicine Zantac Financial Times

GSK Consumer Preps For Independent Future With E-commerce Upgrade - Consumer Goods Technology

GSK Consumer Preps For Independent Future With E-commerce Upgrade Consumer Goods Technology

Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus - Nature

Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus Nature

GSK photovoltaic plant in northern Spain - Arup

GSK photovoltaic plant in northern Spain Arup

GSK completes transaction with Pfizer - PharmaTimes

GSK completes transaction with Pfizer PharmaTimes

Wayne Gretzky has a face-off with his younger self for new GSK Canada RSV vaccine ad - Fierce Pharma

Wayne Gretzky has a face-off with his younger self for new GSK Canada RSV vaccine ad Fierce Pharma

GSK's $100M ADC bet in doubt after fatality in first trial of Mersana's cancer therapy - Fierce Biotech

GSK's $100M ADC bet in doubt after fatality in first trial of Mersana's cancer therapy Fierce Biotech

Disrupting Drug Discovery: How GSK is Using Data More Effectively in R&D to Drive Innovation - drugdiscoverytrends.com

Disrupting Drug Discovery: How GSK is Using Data More Effectively in R&D to Drive Innovation drugdiscoverytrends.com

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease - University of Oxford

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease University of Oxford

Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation - Nature

Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation Nature

GSK to move to ‘simplified’ distribution model - The Pharmaceutical Journal

GSK to move to ‘simplified’ distribution model The Pharmaceutical Journal

GSK‐3β: A Bifunctional Role in Cell Death Pathways - Jacobs - 2012 - International Journal of Cell Biology - Wiley Online Library

GSK‐3β: A Bifunctional Role in Cell Death Pathways - Jacobs - 2012 - International Journal of Cell Biology Wiley Online Library

Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors - Wiley Online Library

Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors Wiley Online Library

GSK fined for deals with competitors - BBC

GSK fined for deals with competitors BBC

2017 CIK-FIA Best-Of: The Rouen GSK 1 team triumphs at Le Mans - Kartcom

2017 CIK-FIA Best-Of: The Rouen GSK 1 team triumphs at Le Mans Kartcom

Andre Vivan da Silva promoted as vice-president and cluster area director for GSK South-Eastern Europe - business-review.eu

Andre Vivan da Silva promoted as vice-president and cluster area director for GSK South-Eastern Europe business-review.eu

GSK fined £22m over paroxetine 'pay for delay' deal - Pharmacy Magazine

GSK fined £22m over paroxetine 'pay for delay' deal Pharmacy Magazine

BUSINESS LIVE: Wetherspoon's returns to profit; CAA to probe August meltdown; GSK sells Haleon stake - This is Money

BUSINESS LIVE: Wetherspoon's returns to profit; CAA to probe August meltdown; GSK sells Haleon stake This is Money

FTSE 100 Live 06 February: AstraZeneca powers index to record, De Beers guidance cut - London Evening Standard

FTSE 100 Live 06 February: AstraZeneca powers index to record, De Beers guidance cut London Evening Standard

13 December 2007: Distribution of medicines - autoritedelaconcurrence.fr

13 December 2007: Distribution of medicines autoritedelaconcurrence.fr

14 March 2007: Sale of drugs to hospitals and private clinics - autoritedelaconcurrence.fr

14 March 2007: Sale of drugs to hospitals and private clinics autoritedelaconcurrence.fr

GSK donates medicines for Sri Lanka's displaced - The Sunday Times, Sri Lanka

GSK donates medicines for Sri Lanka's displaced The Sunday Times, Sri Lanka

Fließgewässer - Gewässerstrukturdaten - Bayerisches Landesamt für Umwelt (LfU)

Fließgewässer - Gewässerstrukturdaten Bayerisches Landesamt für Umwelt (LfU)

Top Gsk Stockmann Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant